Loading viewer...
earnings
Format: PDF earnings
Telix Pharmaceuticals' H1 2023 results presentation covering the company's investigational radiopharmaceutical products and pipeline, including Illuccix® (Ga-68 gozetotide injection). The presentation outlines Telix's activities, financial results, and development progress as of August 2023.
annual_report
14 Pages
earnings
23 Pages
Sonic Drive-In
OMV Q2 2016 Earnings Conference Call
earningsearnings
25 Pages
OMV Aktiengesellschaft
Kuehne + Nagel 2016 Full-Year Results Analyst Conference
earningsearnings
28 Pages
Kuehne + Nagel International